These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29390326)

  • 21. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The usefulness of 18F-FDG-PET/CT in discriminating benign from malignant ovarian teratomas.
    Yokoyama T; Takehara K; Yamamoto Y; Okame S; Shiroyama Y; Yokoyama T; Nogawa T; Sugawara Y
    Int J Clin Oncol; 2015 Oct; 20(5):960-6. PubMed ID: 25681878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma.
    Gontier E; Wartski M; Guinebretiere JM; Alberini JL
    AJR Am J Roentgenol; 2006 Sep; 187(3):W285-9. PubMed ID: 16928906
    [No Abstract]   [Full Text] [Related]  

  • 24. Pediatric growing teratoma syndrome of the ovary: A case report and review of the literature.
    Oyama T; Noda T; Washio K; Shimada A
    Medicine (Baltimore); 2020 Sep; 99(38):e22297. PubMed ID: 32957389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
    Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective comparative study of ultrasonography, contrast-enhanced MRI and 18F-FDG PET/CT for preoperative detection of axillary lymph node metastasis in breast cancer patients.
    Guney IB; Dalci K; Teke ZT; Kucuker KA
    Ann Ital Chir; 2020; 91():458-464. PubMed ID: 32213685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [F-18-FDG positron emission tomography in the diagnosis of ovarian recurrence. Comparison with CT scan and CA 125].
    García Velloso MJ; Boán García JF; Villar Luque LM; Aramendía Beitia JM; López García G; Richter Echeverría JA
    Rev Esp Med Nucl; 2003; 22(4):217-23. PubMed ID: 12846945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin.
    Nikolova PN; Hadzhiyska VH; Mladenov KB; Ilcheva MG; Veneva S; Grudeva VV; Dineva SE; Asenov YN
    Neoplasma; 2021 Jan; 68(1):180-189. PubMed ID: 32880466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-Fluorodeoxyglucose Uptake in Anti-N-Methyl-D-Aspartate-Receptor Encephalitis Associated With an Immature Teratoma.
    Nakamoto R; Nakamoto Y; Ishimori T; Fushimi Y; Togashi K
    Clin Nucl Med; 2017 Feb; 42(2):157-160. PubMed ID: 27922872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer.
    Barranger E; Kerrou K; Petegnief Y; David-Montefiore E; Cortez A; Daraï E
    Gynecol Oncol; 2005 Jan; 96(1):241-4. PubMed ID: 15589609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Value of
    Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
    Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
    Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of preoperative
    Hu J; Zhang K; Yan Y; Zang Y; Wang Y; Xue F
    Arch Gynecol Obstet; 2019 Sep; 300(3):519-529. PubMed ID: 31165242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
    Tan R; Yao SZ; Huang ZQ; Li J; Li X; Tan HH; Liu QW
    Asian Pac J Cancer Prev; 2014; 15(18):7719-24. PubMed ID: 25292052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High impact of FDG-PET/CT in diagnostic strategies for ovarian cancer.
    Zytoon AA; Murakami K; Eid H; El-Gammal M
    Acta Radiol; 2013 Apr; 54(3):340-8. PubMed ID: 23319725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of clinical impact of
    Liu J; Larcos G; Howle J; Veness M
    Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
    Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
    JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Efficacy of 18F-FDG PET/CT and Superparamagnetic Nanoferric Oxide MRI in the Diagnosis of Lung Cancer and the Value of 18F-FDG PET/CT in the Prediction of Lymph Node Metastasis.
    Yao L; Zuo M; Zhang N; Bai T; Huang Q
    Comput Math Methods Med; 2021; 2021():2448782. PubMed ID: 34552658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.